Chargement en cours...
Valsartan Orodispersible Tablets: Formulation, In vitro/In vivo Characterization
Valsartan orodispersible tablets have been developed at 40-mg dose, with the intention of facilitating administration to patients experiencing problems with swallowing and hopefully, improving its poor oral bioavailability. Work started with selecting drug compatible excipients depending on differen...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2850465/ https://ncbi.nlm.nih.gov/pubmed/20112137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-009-9354-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|